Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth R Plimack

Showing results (191-200 of 209) with videos related to

Pageof 21
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|March 4, 2014
Kidney cancer, version 2.2014Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 15, 2026
Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In OncologyThomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 4, 2020
NCCN Guidelines Insights: Kidney Cancer, Version 1.2021Robert J Motzer, Eric Jonasch, Shawna Boyle, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2019
NCCN Guidelines Insights: Kidney Cancer, Version 2.2020Robert J Motzer, Eric Jonasch, M Dror Michaelson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 6, 2022
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyRobert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2020
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in OncologyThomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
The Lancet. Oncology|August 21, 2019
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trialRobert J Motzer, Brian I Rini, David F McDermott, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2024
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 7, 2016
Prostate Cancer, Version 1.2016James L Mohler, Andrew J Armstrong, Robert R Bahnson, et al.
The Lancet. Oncology|March 5, 2019
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort studyNieves Martínez Chanzá, Wanling Xie, Mehmet Asim Bilen, et al.
Pageof 21

Showing results (191-200 of 209) with videos related to

Sort By:
Pageof 21
Journal of the National Comprehensive Cancer Network : JNCCN|March 4, 2014
Kidney cancer, version 2.2014Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 15, 2026
Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In OncologyThomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 4, 2020
NCCN Guidelines Insights: Kidney Cancer, Version 1.2021Robert J Motzer, Eric Jonasch, Shawna Boyle, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2019
NCCN Guidelines Insights: Kidney Cancer, Version 2.2020Robert J Motzer, Eric Jonasch, M Dror Michaelson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 6, 2022
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyRobert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2020
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in OncologyThomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
The Lancet. Oncology|August 21, 2019
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trialRobert J Motzer, Brian I Rini, David F McDermott, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2024
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 7, 2016
Prostate Cancer, Version 1.2016James L Mohler, Andrew J Armstrong, Robert R Bahnson, et al.
The Lancet. Oncology|March 5, 2019
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort studyNieves Martínez Chanzá, Wanling Xie, Mehmet Asim Bilen, et al.
Pageof 21